ERP/HR TOCD RTC

  • Research type

    Research Study

  • Full title

    INTEGRATING EXPOSURE AND RESPONSE PREVENTION AND HABIT REVERSAL TECHNIQUES TO TREAT A TOURETTIC SUBTYPE OF OBSESSIVE-COMPULSIVE DISORDER (TOURETTIC OCD).

  • IRAS ID

    349759

  • Contact name

    Himanshu Tyagi

  • Contact email

    h.tyagi@nhs.net

  • Sponsor organisation

    University College London

  • Clinicaltrials.gov Identifier

    Z6364106/2024/08/162 Health Research, University College London

  • Duration of Study in the UK

    4 years, 10 months, 29 days

  • Research summary

    The symptom overlap between Tic Disorders (TD) and Obsessive Compulsive Disorder (OCD) has continued to spark interest over the decades. Independently, these neuropsychiatric disorders have been the subject of intense speculation since at least the eighteenth century. Despite the overt symptomology associated with both, a subcategory of patient(s) (i.e., those with a Tourettic Subtype of Obsessive-Compulsive Disorder) exist that seek treatment with distinct set of symptoms that are similar to both TD and OCD yet remarkably different. Standardized treatments are most commonly provided to this patient population, yet these interventions seldom address the overlapping features of their clinical presentation.

    TRIAL PARTICIPANTS TO BE RANDOMIZED INTO ONE OF THE FOUR TRIAL ARMS (I.E., GROUP 1: HYBRID COMBINATION OF EXPOSURE AND RESPONSE PREVENTION AND HABIT REVERSAL TRAINING, GROUP 2: PURE EXPOSURE AND RESPONSE PREVENTION; GROUP 3: PURE HABIT REVERSAL TRAINING; AND GROUP 4: ACTIVE SUPPORTIVE PSYCHOTHERAPY AND PSYCHOEDUCATION CONTROL). ALL TRIAL ARMS WILL BE COMPRISED OF TWELVE CONSECUTIVE WEEKS OF ONE-TO-ONE FACE-TO-FACE SIXTY MINUTE PSYCHOTHERAPY APPOINTMENTS AND A FOLLOW-UP APPOINTMENT AT WEEK TWENTY-FOUR

    By introducing a contemporary framework of investigation, casting a light on this clinical phenomenon (i.e., Tourettic Subtype of Obsessive-Compulsive Disorder) may well fill in gaps in the literature. Perhaps, most importantly, it is believed that this progressive step will assist (i) clinicians in determining the optimal strategy or sequence of strategies for addressing the symptom blend by providing empirically informed recommendations on diagnostics, treatment, and prognosis and (ii) patients in terms of accessing suitable and appropriate healthcare.

  • REC name

    North East - Newcastle & North Tyneside 2 Research Ethics Committee

  • REC reference

    25/NE/0058

  • Date of REC Opinion

    29 May 2025

  • REC opinion

    Further Information Favourable Opinion